TerrAscend Corp. (OTC:TSNDF – Free Report) – Equities researchers at Seaport Res Ptn cut their FY2024 earnings estimates for TerrAscend in a report released on Monday, November 18th. Seaport Res Ptn analyst S. Randhawa now expects that the company will post earnings per share of ($0.18) for the year, down from their previous forecast of ($0.15). The consensus estimate for TerrAscend’s current full-year earnings is ($0.17) per share. Seaport Res Ptn also issued estimates for TerrAscend’s Q4 2024 earnings at ($0.04) EPS, Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.15) EPS.
TerrAscend Stock Down 7.2 %
Shares of TSNDF stock opened at $0.77 on Thursday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a 12-month low of $0.66 and a 12-month high of $2.45. The business’s fifty day simple moving average is $1.11.
About TerrAscend
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Recommended Stories
- Five stocks we like better than TerrAscend
- Best Aerospace Stocks Investing
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Buy P&G Now, Before It Sets A New All-Time High
- Williams-Sonoma Stock: Buy It and Never Let It Go
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
